Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Loïc Reppel(University of North Carolina at Chapel Hill), Barbara Savoldo(University of North Carolina at Chapel Hill)

Journal for ImmunoTherapy of Cancer

January 1, 2022

10.1136/jitc-2021-003897

Cited by 72

Related Papers

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model

|Blood|2009|523

Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes

|Journal of Clinical Investigation|2017|368